With the increased disability associated with osteoarthritis (OA) progression, and the significant socioeconomic burden of joint replacement surgeries, there is a need for more reliable conservative treatments for patients presenting with hip OA. Most studies of OA treatments involve the knee. We conducted a literature search and reviewed non-operative hip OA treatment recommendations by the Osteoarthritis Research Society International, the American College of Rheumatology, American Academy of Orthopedic Surgeons, and European Alliance of Associations for Rheumatology, as well as Cochrane Reviews. Non-steroidal anti-inflammatory drugs and corticosteroid injections are the most supported and recommended options for hip OA; other medications with potential benefits for short-term pain relief include acetaminophen and tramadol. Most societies recommend against the use of glucosamine, typical opioids, and viscosupplementation injections. Platelet-rich plasma has potential benefits, but evidence of its effectiveness is incomplete. Further research is needed to better inform and guide clinicians who create treatment plans for patients with symptomatic hip OA.
AtchiaIKaneDReedMRIsaacsJDBirrellF.Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Dis. 2011;70(1):110–116. https://doi.org/10.1136/ard.2009.127183.
5.
BannuruRROsaniMCVaysbrotEE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589. https://doi.org/10.1016/j.joca.2019.06.011.
6.
BattagliaMGuaraldiFVanniniF, et al. Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics. 2013;36(12):e1501–e1508. https://doi.org/10.3928/01477447-20131120-13.
7.
BellamyNCampbellJWelchV, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database of Systematic Reviews. 2006;2:CD005321. https://doi.org/10.1002/14651858.CD005321.pub2.
8.
BocanegraTSWeaverALTindallEA, et al. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group. J Rheumatol. 1998;25(8):1602–1611.
9.
BottingRAyoubSS.Cox-3 and the mechanism of action of paracetamol/acetaminophen. Prostaglandins Leukot Essent Fatty Acids. 2005;72(2):85–87. https://doi.org/10.1016/j.plefa.2004.10.005.
10.
CannonGWCaldwellJRHoltP, et al. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group. Arthritis Rheum. 2000;43(5):978–987. https://doi.org/10.1002/1529-0131(200005)43:5<978::Aid-anr4>3.0.Co;2-0.
11.
ChandrasekaranSDarwishNGuiC, et al. Outcomes of hip arthroscopy in patients with Tönnis grade-2 osteoarthritis at a mean 2-year follow-up: evaluation using a matched-pair analysis with Tönnis grade-0 and grade-1 cohorts. J Bone Joint Surg Am. 2016;98(12):973–982. https://doi.org/10.2106/jbjs.15.00644.
12.
ChandrasekaranSLodhiaPSuarez-AhedoC, et al. Symposium: evidence for the use of intra-articular cortisone or hyaluronic acid injection in the hip. J Hip Preserv Surg. 2016;3(1):5–15. https://doi.org/10.1093/jhps/hnv020.
ChoueiriMChevalierXEymardF.Intraarticular corticosteroids for hip osteoarthritis: a review. Cartilage. 2021;13(suppl 1):122S–131S. https://doi.org/10.1177/1947603520951634.
15.
CibulkaMTBloomNJEnsekiKR, et al. Hip pain and mobility deficits-hip osteoarthritis: revision 2017. J Orthop Sports Phys Ther. 2017;47(6):A1–A37. https://doi.org/10.2519/jospt.2017.0301.
CrossMSmithEHoyD, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323–1330. https://doi.org/10.1136/annrheumdis-2013-204763.
18.
da CostaBRNüeschEKastelerR, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev. 2014;9:CD003115. https://doi.org/10.1002/14651858.CD003115.pub4.
19.
da CostaBRReichenbachSKellerN, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017;390(10090):e21–e33. https://doi.org/10.1016/s0140-6736(17)31744-0.
20.
DerwichMMitus-KenigMPawlowskaE.Mechanisms of action and efficacy of hyaluronic acid, corticosteroids and platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis-a systematic review. Int J Mol Sci. 2021;22(14):7405. https://doi.org/10.3390/ijms22147405.
DoldAPZywielMGTaylorDWDwyerTTheodoropoulosJ.Platelet-rich plasma in the management of articular cartilage pathology: a systematic review. Clin J Sport Med. 2014;24(1):31–43. https://doi.org/10.1097/01.jsm.0000432855.85143.e5.
Fernández LópezJCRuano-RavinaA.Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review. Osteoarthritis Cartilage. 2006;14(12):1306–1311. https://doi.org/10.1016/j.joca.2006.08.003.
25.
FlanaganJCasaleFFThomasTLDesaiKB.Intra-articular injection for pain relief in patients awaiting hip replacement. Ann R Coll Surg Engl. 1988;70(3):156–157.
26.
GeenenROvermanCLChristensenR, et al. EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018;77(6):797–807. https://doi.org/10.1136/annrheumdis-2017-212662.
27.
GerrietsVAndersonJNappeTM.Acetaminophen. In: Statpearls. Treasure Island, FL: StatPearls Publishing; 2023.
28.
GibofskyAHochbergMCJarosMJYoungCL.Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study. Curr Med Res Opin. 2014;30(9):1883–1893. https://doi.org/10.1185/03007995.2014.946123.
29.
GoreMTaiKSSadoskyALeslieDStaceyBR.Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings. Pain Pract. 2012;12(7):550–560. https://doi.org/10.1111/j.1533-2500.2012.00532.x.
HermansJKoopmanschapMABierma-ZeinstraSM, et al. Productivity costs and medical costs among working patients with knee osteoarthritis. Arthritis Care Res (Hoboken). 2012;64(6):853–861. https://doi.org/10.1002/acr.21617.
33.
HunterDJSchofieldDCallanderE.The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol. 2014;10(7):437–441. https://doi.org/10.1038/nrrheum.2014.44.
34.
JordanJMHelmickCGRennerJB, et al. Prevalence of hip symptoms and radiographic and symptomatic hip osteoarthritis in African Americans and Caucasians: the Johnston County osteoarthritis project. J Rheumatol. 2009;36(4):809–815. https://doi.org/10.3899/jrheum.080677.
KivitzAJMoskowitzRWWoodsE, et al. Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip. J Int Med Res. 2001;29(6):467–479. https://doi.org/10.1177/147323000102900602.
38.
KohnMDSassoonAAFernandoND.Classifications in brief: Kellgren-Lawrence classification of osteoarthritis. Clin Orthop Relat Res. 2016;474(8):1886–1893. https://doi.org/10.1007/s11999-016-4732-4.
39.
KolasinskiSLNeogiTHochbergMC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220–233. https://doi.org/10.1002/art.41142.
40.
KompelAJRoemerFWMurakamiAM, et al. Intra-articular corticosteroid injections in the hip and knee: perhaps not as safe as we thought?Radiology. 2019;293(3):656–663. https://doi.org/10.1148/radiol.2019190341.
KraeutlerMJHouckDAGarabekyanT, et al. Comparing intra-articular injections of leukocyte-poor platelet-rich plasma versus low-molecular weight hyaluronic acid for the treatment of symptomatic osteoarthritis of the hip: a double-blind, randomized pilot study. Orthop J Sports Med. 2021;9(1):2325967120969210. https://doi.org/10.1177/2325967120969210.
43.
KruseDW.Intraarticular cortisone injection for osteoarthritis of the hip. Is it effective? is it safe?Curr Rev Musculoskelet Med. 2008;1(3–4):227–233. https://doi.org/10.1007/s12178-008-9029-0.
44.
KullenbergBRunessonRTuvhagROlssonCReschS.Intraarticular corticosteroid injection: pain relief in osteoarthritis of the hip?J Rheumatol. 2004;31(11):2265–2268.
45.
LaiQCaiKLinT, et al. Prior intra-articular corticosteroid injection within 3 months may increase the risk of deep infection in subsequent joint arthroplasty: a meta-analysis. Clin Orthop Relat Res. 2022;480(5):971–979. https://doi.org/10.1097/corr.0000000000002055.
46.
LambertRGHutchingsEJGraceMG, et al. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2007;56(7):2278–2287. https://doi.org/10.1002/art.22739.
47.
MarksDMShahMJPatkarAA, et al. Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise. Curr Neuropharmacol. 2009;7(4):331–336. https://doi.org/10.2174/157015909790031201.
48.
McAlindonTELaValleyMPHarveyWF, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967–1975. https://doi.org/10.1001/jama.2017.5283.
49.
MiglioreAGranataM.Intra-articular use of hyaluronic acid in the treatment of osteoarthritis. Clin Interv Aging. 2008;3(2):365–369. https://doi.org/10.2147/cia.s778.
50.
NeidelJBoehnkeMKüsterRM.The efficacy and safety of intraarticular corticosteroid therapy for coxitis in juvenile rheumatoid arthritis. Arthritis Rheum. 2002;46(6):1620–1628. https://doi.org/10.1002/art.10313.
NhoSJKymesSMCallaghanJJFelsonDT.The burden of hip osteoarthritis in the united states: epidemiologic and economic considerations. J Am Acad Orthop Surg. 2013;21(suppl 1):S1–S6. https://doi.org/10.5435/jaaos-21-07-s1.
53.
NieFLiW.Impact of prior intra-articular injections on the risk of prosthetic joint infection following total joint arthroplasty: a systematic review and meta-analysis. Front Surg. 2021;8:737529. https://doi.org/10.3389/fsurg.2021.737529.
54.
ParedesSCantilloSCandidoKDKnezevicNN.An association of serotonin with pain disorders and its modulation by estrogens. Int J Mol Sci. 2019;20(22):5729. https://doi.org/10.3390/ijms20225729.
QvistgaardEChristensenRTorp-PedersenSBliddalH.Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage. 2006;14(2):163–170. https://doi.org/10.1016/j.joca.2005.09.007.
57.
RichettePRavaudPConrozierT, et al. Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial. Arthritis Rheum. 2009;60(3):824–830. https://doi.org/10.1002/art.24301.
SánchezMGuadillaJFizNAndiaI.Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology (Oxford). 2012;51(1):144–150. https://doi.org/10.1093/rheumatology/ker303.
60.
SchairerWWNwachukwuBUMaymanDJLymanSJerabekSA.Preoperative hip injections increase the rate of periprosthetic infection after total hip arthroplasty. J Arthroplasty. 2016;31(supp 9):166–169.e1. https://doi.org/10.1016/j.arth.2016.04.008.
61.
ScheimanJM.The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage. Arthritis Res Ther. 2013;15(suppl 3):S5. https://doi.org/10.1186/ar4177.
62.
SharifBGarnerRHennessyD, et al. Productivity costs of work loss associated with osteoarthritis in Canada from 2010 to 2031. Osteoarthritis Cartilage. 2017;25(2):249–258. https://doi.org/10.1016/j.joca.2016.09.011.
SkouSTRoosEM.Physical therapy for patients with knee and hip osteoarthritis: supervised, active treatment is current best practice. Clin Exp Rheumatol. 2019;37(5):112–117.
66.
SmithJHurdleMFWeingartenTN.Accuracy of sonographically guided intra-articular injections in the native adult hip. J Ultrasound Med. 2009;28(3):329–335. https://doi.org/10.7863/jum.2009.28.3.329.
67.
TerjesenTGundersonRB.Radiographic evaluation of osteoarthritis of the hip: an inter-observer study of 61 hips treated for late-detected developmental hip dislocation. Acta Orthop. 2012;83(2):185–189. https://doi.org/10.3109/17453674.2012.665331.
Uusi-RasiKPatilRKarinkantaS, et al. Exercise training in treatment and rehabilitation of hip osteoarthritis: a 12-week pilot trial. J Osteoporos. 2017;2017:3905492. https://doi.org/10.1155/2017/3905492.
71.
ValeraMIbañezNSanchoRTeyM.Reliability of Tönnis classification in early hip arthritis: a useless reference for hip-preserving surgery. Arch Orthop Trauma Surg. 2016;136(1):27–33. https://doi.org/10.1007/s00402-015-2356-x.
72.
VelliosEE.Rich or poor? examining platelet-rich plasma leukocyte concentration in knee osteoarthritis: commentary on article by Aazad Abbas, HBSc, et al.: “the effect of leukocyte concentration on platelet-rich plasma injections for knee osteoarthritis. A network meta-analysis.”J Bone Joint Surg Am. 2022;104(6):e26. https://doi.org/10.2106/jbjs.21.01186.
73.
VilloutreixCPhamTTubachFDougadosMAyralX.Intraarticular glucocorticoid injections in rapidly destructive hip osteoarthritis. Joint Bone Spine. 2006;73(1):66–71. https://doi.org/10.1016/j.jbspin.2005.06.002.
74.
VowlesKEMcEnteeMLJulnesPS, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569–576. https://doi.org/10.1097/01.j.pain.0000460357.01998.f1.
75.
WylesCCHeidenreichMJJengJ, et al. The John Charnley award: redefining the natural history of osteoarthritis in patients with hip dysplasia and impingement. Clin Orthop Relat Res. 2017;475(2):336–350. https://doi.org/10.1007/s11999-016-4815-2.
76.
YamamotoTSchneiderRIwamotoYBulloughPG.Rapid destruction of the femoral head after a single intraarticular injection of corticosteroid into the hip joint. J Rheumatol. 2006;33(8):1701–1704.
77.
YaradilmisYUDemirkaleISafa TagralA, et al. Comparison of two platelet rich plasma formulations with viscosupplementation in treatment of moderate grade gonarthrosis: a prospective randomized controlled study. J Orthop. 2020;20:240–246. https://doi.org/10.1016/j.jor.2020.01.041.
78.
YocumDFleischmannRDalginP, et al. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The meloxicam osteoarthritis investigators. Arch Intern Med. 2000;160(19):2947–2954. https://doi.org/10.1001/archinte.160.19.2947.
79.
ZengCLaneNEHunterDJ, et al. Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the osteoarthritis initiative. Osteoarthritis Cartilage. 2019;27(6):855–862. https://doi.org/10.1016/j.joca.2019.01.007.
80.
ZhangWDohertyMArdenN, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis. 2005;64(5):669–681. https://doi.org/10.1136/ard.2004.028886.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
